FY2025 · ended Dec 31, 2025 · Revenue $270.28M, +20.5% YoY · Filed Mar 4, 2026
Viemed Healthcare, Inc. (VMD) files with the SEC under industry code 8090, Services-Misc Health & Allied Services, NEC. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $270.3 million and net income of $14.9 million. Free cash flow was $11.9 million. As of Sep 30, 2026 it held $9.7 million in cash and investments and $9.3 million in total debt.
Revenue (TTM)
$310.37M
+21.8% vs year-ago TTM
Net income (TTM)
$15.62M
+14.8% vs year-ago TTM
Operating cash flow (TTM)
$53.90M
+11.2% vs year-ago TTM
Free cash flow (TTM)
$21.38M
+297.0% vs year-ago TTM
EPS (TTM)
$0.38
+15.8% vs year-ago TTM
Dividend per share
None
Shares outstanding
38.60M
-2.3% vs prior year
Net cash
$393,000
as of Sep 30, 2026
Operating margin
7.8%
FY 2026
Company profile
- Industry
- Services-Misc Health & Allied Services, NEC (SIC 8090)
- Listed as
- VMD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Lafayette, LA
- SEC filer status
- Accelerated filer
- SEC CIK
- 1729149
Other Services-Misc Health & Allied Services, NEC companies
- Fresenius Medical Care AG FMS
- Davita Inc. DVA
- Sotera Health Co SHC
- Progyny, Inc. PGNY
- agilon health, inc. AGL
- Charming Medical Ltd MCTA
- Park Dental Partners, Inc. PARK
- Marpai, Inc. MRAI
All 15 Services-Misc Health & Allied Services, NEC companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $270.3M | $224.3M | $183.0M | $138.8M | $117.1M |
| Operating income | $22.9M | $17.9M | $14.3M | $8.3M | $11.6M |
| Net income | $14.9M | $11.3M | $10.2M | $6.2M | $9.1M |
| Diluted EPS | $0.37 | $0.28 | $0.25 | $0.16 | $0.22 |
| Operating cash flow | $51.9M | $39.1M | $45.2M | $27.7M | $22.5M |
| Free cash flow | $11.9M | $1.3M | $19.1M | $4.8M | $2.8M |
| Total assets | $199.2M | $177.1M | $154.9M | $117.0M | $118.0M |
| Total liabilities | $55.6M | $43.8M | $41.0M | $19.9M | $23.1M |
| Stockholders' equity | $141.5M | $131.4M | $113.9M | $97.1M | $94.8M |
| Cash and investments | $13.5M | $17.5M | $12.8M | $16.9M | $28.4M |
| Total debt | $15.9M | $6.9M | $10.3M | $0 | $5.8M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 20, 2026 | Aug 20, 2026 |
| 10-Q | Quarterly report | Aug 3, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2026 | Aug 3, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 4, 2026 | Jun 4, 2026 |
All 419 Viemed Healthcare, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.